Navigation Links
PDL BioPharma Announces First Quarter 2009 Financial Results
Date:5/7/2009

of its annual and quarterly reports filed with the SEC. Copies of PDL's filings with the SEC may be obtained at the "Investors" section of PDL's website at www.pdl.com. PDL expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in PDL's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based for any reason, except as required by law, even as new information becomes available or other events occur in the future. All forward-looking statements in this press release are qualified in their entirety by this cautionary statement.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc. 

                           ~financial statements to follow~


                                  PDL BIOPHARMA, INC.
                    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                       (in thousands, except per share amounts)
                                      (unaudited)

                                             Three Months Ended March 31,
                                            2009                      2008
    Revenues                              $62,622                   $50,205
    General and administrative expenses     4,693                    12,709
        Operating income                   57,929                    37,496
    Interest and other income, net            336                     4,864
    Interest expense                       (3,574)                   (3,555)
        Income from continuing
         operations before income
         taxes                             54,691                    38,805
    Income tax expense                     17,234                     1,034
        Income fr
'/>"/>
SOURCE  PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 

Related biology technology :

1. Sinobiopharma Secures Rights to Seven Key Patents
2. China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India
3. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
4. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
5. Helix BioPharma to Present at the BioFinance 2009 Conference
6. Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
7. 2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
8. Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research
9. Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry
10. XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel
11. Sinobiopharma, Inc. Appoints New Director of Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2010)... Md. , March 17  OriGene Technologies, ... completion of a $16 million Series B ... Enterprise, and Zero2IPO. OriGene,s previous investors Morningside ... participated in this round.  The proceeds from the funding ...
(Date:3/17/2010)... ... ... 17, 2010 -- Studies released today at a symposium today in Washington, D.C. underscored ... importance of continued innovation and new technologies to meeting growing global food, feed, fiber ...
(Date:3/17/2010)... Initial public offerings for LinkedIn and Dunkin Donuts, takeovers of Mead Johnson Nutrition and Harley-Davidson, and a Cold Stone Creamery sale are among the 10 deals predicted by columnists from Dow ... ... ... ...
(Date:3/17/2010)... BRIDGEWATER, N.J. , March 17 Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that it has ... ... ... ...
Breaking Biology Technology:OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome 2OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome 3Global Food Security Depends on Modern Agriculture 2Global Food Security Depends on Modern Agriculture 3Global Food Security Depends on Modern Agriculture 4From Donuts To Hogs - Which Brand Icons Might Be In Play? 2From Donuts To Hogs - Which Brand Icons Might Be In Play? 3From Donuts To Hogs - Which Brand Icons Might Be In Play? 4From Donuts To Hogs - Which Brand Icons Might Be In Play? 5From Donuts To Hogs - Which Brand Icons Might Be In Play? 6From Donuts To Hogs - Which Brand Icons Might Be In Play? 7From Donuts To Hogs - Which Brand Icons Might Be In Play? 8Valeritas Announces Appointment of New CFO 2Valeritas Announces Appointment of New CFO 3
... Kendle (Nasdaq: KNDL ), a,leading, global ... Chief Executive Officer Candace Kendle, PharmD,will participate in ... held at the Langham Hotel in Boston, Jan. ... 30 at 1:30 p.m. Eastern Time., (Logo: ...
... JAMESBURG, N.J., Jan 28 Phytomedics Inc., a ... products, announced today that it will present at ... Wednesday,January 30th, at 1:00 p.m. ET., Among ... overview of Phytomedics,strategic focus and business developments, including ...
... N.C., Jan. 28 Campbell Alliance, the leading,management ... today announced that Nader Naeymi-Rad, Senior,Vice President of ... the,EyeForPharma Oncology Summit Europe. The event will be ... Marriott Hotel in London, England., Mr. Naeymi-Rad,s ...
Other Biology Technology:Kendle to Present at the Wachovia 2008 Healthcare Conference 2Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit 2
(Date:3/17/2010)... sound like a mashup of monster movies, but palaeontologists have ... reconstructing a killing that took place 4 million years ago. ... but by careful, forensic-style analysis of bite marks on an ... Italy, have reconstructed the events that led to the death ...
(Date:3/17/2010)... 17, 2010) More than 1600 basic research scientists ... flies) are expected to attend the 51st Annual ... 2010. , Representatives of the media are ... poster and workshop sessions. Eligible media will receive complimentary ...
(Date:3/17/2010)... This release is available in French ... switches on an extremely important process for the proper ... fast-track transportation pathway of ,cargo, to and from the ... can have severe consequences, leading to numerous diseases such ...
Breaking Biology News(10 mins):Jaws -- 4 million B.C. 2Genetics Society of America's 51st Annual Drosophila Research Conference 2Genetics Society of America's 51st Annual Drosophila Research Conference 3Genetics Society of America's 51st Annual Drosophila Research Conference 4Getting turned on 2Getting turned on 3Gamida Cell and Cellerix Partner on Feasibility Study 14558 1Gamida Cell and Cellerix Partner on Feasibility Study 14558 2Gamida Cell and Cellerix Partner on Feasibility Study 14558 3Delcath Systems Inc Completes Phase III Study Enrollment 5635 1Delcath Systems Inc Completes Phase III Study Enrollment 5635 2Delcath Systems Inc Completes Phase III Study Enrollment 5635 3NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 1NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 2
... genomics milestone, an international consortium of researchers has for the ... by sequencing the genome ?or set of all genes ?of ... that causes rice blast disease. , Dr. Ralph Dean, professor ... Center for Integrated Fungal Research, is the lead author of ...
... a flashlight with your hand and seen the red light ... the therapeutic window ?that magic wavelength that is not absorbed ... use light at that wavelength to signal manmade molecules to ... possibilities will be discussed in a poster and a talk ...
... infectious misformed proteins cause mad cow disease and ... University of Texas Medical Branch at Galveston (UTMB) ... mysterious and devastating brain diseases known as "transmissible ... agent composed only of a malformed protein, and ...
Other Biology News:Researchers uncover sequence of major rice pathogen 2Researchers uncover sequence of major rice pathogen 3Medical molecules designed to respond to visible light that can penetrate tissue 2Strongest proof yet found for prion hypothesis 2
... steadylite plus assay system offers ... sensitivity, Designed for batch-processing systems, ... higher density microplates such as ... free, Convenient storage conditions ( ...
...
... Grace's Insect Medium is formuatled ... lines including Sf9 and Sf21 cells. ... for transfectioin because it does not ... can interfere with transfection. Grace's Insect ...
D.R. Harper (1993) • Includes: essential information on taxonomy, culture and safe handling of viruses, immunology, monoclonal antibodies, antivirals and vaccines....
Biology Products: